Medical System Network Co., Ltd. (JP:4350)
:4350
Want to see JP:4350 full AI Analyst Report?
Top Page
Medical System Network Co., Ltd.
(4350)
Select Model
Select Model
Rating:54Neutral
Price Target:
¥515.00
▼(-1.15% Downside)
Action:Downgraded
Date:05/09/26
The score is held back primarily by deteriorating financial quality—especially the shift to negative operating and free cash flow in 2026—alongside weak technical momentum (below key moving averages and negative MACD). The main offset is attractive valuation (low P/E and a moderate dividend yield).
Positive Factors
Consistent Revenue Growth
Mid-single-digit revenue growth over recent years indicates durable end-market demand and successful commercial execution. Sustained top-line expansion supports scale economics, helps absorb fixed costs, and provides a platform for margin recovery if cost pressures are managed.
Negative Factors
Negative Operating & Free Cash Flow
A sharp cash-flow reversal in 2026 signals working-capital strain or higher cash outlays, undermining the company's ability to self-fund growth, capex, or distributions. Persistent cash burn increases dependence on external financing and heightens liquidity and refinancing risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Mid-single-digit revenue growth over recent years indicates durable end-market demand and successful commercial execution. Sustained top-line expansion supports scale economics, helps absorb fixed costs, and provides a platform for margin recovery if cost pressures are managed.
Read all positive factors
Medical System Network Co., Ltd. (4350) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥14.64B
Dividend Yield2.32%
Average Volume (3M)49.94K
Price to Earnings (P/E)14.7
Beta (1Y)0.75
Revenue Growth8.01%
EPS Growth-15.21%
CountryJP
Employees3,744
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)40.04
Shares Outstanding30,642,600
10 Day Avg. Volume63,720
30 Day Avg. Volume49,936
Financial Highlights & Ratios
PEG Ratio-0.97
Price to Book (P/B)0.91
Price to Sales (P/S)0.12
P/FCF Ratio-2.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)99.2
Revenue Forecast (FY)¥134.00B
Medical System Network Co., Ltd. Business Overview & Revenue Model
Company Description
Medical System Network Co., Ltd. distributes pharmaceutical products for pharmacies, hospitals, clinics, and pharmaceutical wholesalers. The company operates through Community Pharmacy Network, Leasing and Facility-related, Meal Catering, and Othe...
How the Company Makes Money
null...
Medical System Network Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
58
Neutral
Cash Flow
39
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.07B | 132.19B | 122.39B | 115.36B | 109.55B | 106.69B |
| Gross Profit | 51.41B | 52.77B | 49.60B | 47.93B | 45.92B | 44.43B |
| EBITDA | 6.48B | 3.31B | 6.42B | 6.90B | 6.25B | 7.05B |
| Net Income | 1.17B | 1.07B | 1.26B | 1.86B | 1.61B | 2.39B |
Balance Sheet | ||||||
| Total Assets | 71.78B | 80.10B | 70.63B | 68.19B | 66.27B | 62.98B |
| Cash, Cash Equivalents and Short-Term Investments | 8.74B | 7.74B | 8.46B | 8.27B | 8.14B | 8.20B |
| Total Debt | 25.01B | 37.67B | 29.79B | 29.18B | 30.52B | 29.57B |
| Total Liabilities | 55.52B | 62.68B | 54.28B | 52.97B | 51.78B | 49.69B |
| Stockholders Equity | 16.16B | 17.29B | 16.26B | 15.17B | 14.45B | 13.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.93B | 1.75B | 5.62B | 3.37B | 1.88B |
| Operating Cash Flow | 0.00 | -3.44B | 4.46B | 7.72B | 4.97B | 4.01B |
| Investing Cash Flow | 0.00 | -4.04B | -3.73B | -3.65B | -2.11B | -2.51B |
| Financing Cash Flow | 0.00 | 6.79B | -544.00M | -3.94B | -2.92B | -3.42B |
Medical System Network Co., Ltd. Technical Analysis
Neutral
521.00
Price Trends
523.24
Positive
515.26
Positive
495.22
Positive
Market Momentum
5.96
Positive
51.20
Neutral
38.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4350, the sentiment is Neutral. The current price of 521 is below the 20-day moving average (MA) of 537.21, below the 50-day MA of 523.24, and above the 200-day MA of 495.22, indicating a neutral trend. The MACD of 5.96 indicates Positive momentum. The RSI at 51.20 is Neutral, neither overbought nor oversold. The STOCH value of 38.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4350.
Medical System Network Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥439.63B | 14.57 | 11.37% | 3.04% | 5.08% | 2.07% | |
67 Neutral | ¥368.12B | 16.82 | ― | 0.41% | 14.59% | 7.84% | |
66 Neutral | ¥580.69B | 17.44 | 15.71% | 0.96% | 15.07% | 72.98% | |
62 Neutral | ¥947.68B | 19.41 | ― | 1.72% | ― | ― | |
60 Neutral | ¥499.01B | 16.97 | ― | 0.93% | 6.74% | 6.60% | |
54 Neutral | ¥14.64B | 14.74 | ― | 2.32% | 8.01% | -15.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:4350
Medical System Network Co., Ltd.
483.00
54.18
12.63%
JP:9989
Sundrug Co
3,748.00
-653.52
-14.85%
JP:7649
Sugi Holdings Co
3,026.00
-67.40
-2.18%
JP:3391
TSURUHA Holdings
2,031.00
-166.07
-7.56%
JP:3349
COSMOS Pharmaceutical Corporation
6,169.00
-2,844.15
-31.56%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,861.00
333.32
9.45%
Medical System Network Co., Ltd. Corporate Events
Medical System Network Posts Higher Sales but Lower Profit and Guides Weaker Outlook
May 8, 2026
Medical System Network reported consolidated net sales of ¥132.2 billion for the year ended March 31, 2026, up 8.0% year on year, with EBITDA rising modestly to ¥6.73 billion and operating profit increasing 5.0% to ¥3.31 billion. Pr...
Medical System Network Grows Sales but Faces Profit Pressure in Q3 FY2026
Feb 13, 2026
Medical System Network Co., Ltd. reported that its pharmacy support businesses, including the pharmaceutical network, are steadily expanding, with a growing number of pharmacies using its services and new community pharmacies opened in the previou...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.